PRIMARY PERITONEAL SEROUS ADENOCARCINOMA
Clinical trials for PRIMARY PERITONEAL SEROUS ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PRIMARY PERITONEAL SEROUS ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for PRIMARY PERITONEAL SEROUS ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Ovarian cancer vaccine shows promise in small safety trial
⭐️ VACCINE ⭐️ CompletedThis early-stage study tested a custom-made vaccine for people with advanced ovarian, fallopian tube, or primary peritoneal cancer. The vaccine was made from each patient's own white blood cells and designed to train the immune system to attack cancer cells. The main goal was to …
Matched conditions: PRIMARY PERITONEAL SEROUS ADENOCARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Mayo Clinic • Aim: ⭐️ VACCINE ⭐️
Last updated May 12, 2026 13:40 UTC
-
New drug shows promise for slowing Low-Grade ovarian cancer
Disease control CompletedThis study tested the drug trametinib in 260 people with low-grade ovarian or peritoneal cancer that had returned or spread. The goal was to see if trametinib could slow cancer growth better than standard treatments like hormone therapy or chemotherapy. Participants were randomly…
Matched conditions: PRIMARY PERITONEAL SEROUS ADENOCARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 16:03 UTC